Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Update

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a significant drop in short interest in the month of August. As of August 14th, there was short interest totaling 20,858 shares, a drop of 86.5% from the July 30th total of 154,671 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 2,242,858 shares, the days-to-cover ratio is presently 0.0 days.

Azitra Trading Up 12.3%

Azitra stock traded up $0.02 on Wednesday, hitting $0.18. The company’s stock had a trading volume of 2,596,560 shares, compared to its average volume of 9,660,498. The company has a fifty day moving average price of $0.15 and a 200-day moving average price of $0.19. Azitra has a one year low of $0.10 and a one year high of $1.36.

Azitra (NYSEAMERICAN:AZTR) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05). On average, analysts expect that Azitra will post -0.25 EPS for the current year.

About Azitra

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.